Bloomberg Law
Drug Diagnosis Code Data Sought by HHS OIG May Cue Enforcement
July 12, 2021
Leadership from HHS-OIG recently advocated for new mandates that physicians include a diagnosis code with each prescription and that claims data capture this information. This followed on the heels of a Congressional Research Service report suggesting that Congress should pass legislation requiring healthcare providers to include diagnostic information in prescriptions. As Sidley lawyers Jaime L.M. Jones, Brenna E. Jenny, and Matt Bergs discuss, HHS-OIG may see diagnosis code data as a tool to engage in nuanced investigations into pharmaceutical companies for off-label promotion of prescription drugs, leveraging law enforcement’s increasingly sophisticated capacity to use data analytics to identify targets for investigation.
Contacts
Related Blogs
Capabilities
Suggested News & Insights
First Circuit Clarifies Application of Medicare’s “Reasonable and Necessary” Standard in FCA Cases Against Clinical LabsDecember 8, 2025Sidley Secures Landmark FCA Defense Victory for Novo NordiskNovember 18, 2025U.S. DOJ Announces Renewal of FCA Working GroupNovember - December 2025U.S. Treasury Launches Departmentwide Review of Preference-Based Contracting ProgramsNovember 11, 2025Torrey Cope Featured on Fierce Biotech's The Top Line Podcast Episode, "Unpacking the FDA Transparency Push on CRLs"October 17, 2025DOJ Announces Renewal of FCA Working GroupOctober 2025
- Stay Up To DateSubscribe to Sidley Publications
- Follow Sidley on Social MediaSocial Media Directory

